Treatment of pulmonary tuberculosis;Tratamiento de la tuberculosis pulmonar

Anales de Pediatria

Volumn 66, Issue SUPPL.2, 2007, Pages 52-62

  Baquero Artigao, Fernando ^a  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

Antitubercular agents; Children; Drug resistance; Treatment; Tuberculosis

Indexed keywords

AMIKACIN; ANTICONVULSIVE AGENT; CAPREOMYCIN; CARBAMAZEPINE; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSERINE; DEXAMETHASONE; DIAZEPAM; DISULFIRAM; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; KANAMYCIN; KETOCONAZOLE; LEVOFLOXACIN; LINEZOLID; METHADONE; MOXIFLOXACIN; ORAL CONTRACEPTIVE AGENT; PREDNISONE; PROPRANOLOL DERIVATIVE; PROTIONAMIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFATER; RIMCURE; RIMSTAR; STREPTOMYCIN; TISOBRIF; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; WARFARIN;

CONFERENCE PAPER; DIRECTLY OBSERVED THERAPY; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG SENSITIVITY; EOSINOPHILIA; FEVER; HEMOLYSIS; HUMAN; IMMIGRANT; INCIDENCE; KIDNEY INJURY; LUNG DISEASE; MULTIDRUG RESISTANCE; NONHUMAN; PATIENT MONITORING; PEDIATRICS; PREVALENCE; PRURITUS; RISK FACTOR; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULOSIS; URTICARIA; VASCULITIS;

EID: 34547739075     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. a ed. Barcelona: Sociedad Española de Quimioterapia y Prous Science, S.A.; 2006. p. 607-20.
2. Aguado JM, Rufí G, García-Rodríguez JF, Solera J, Moreno S. Tuberculosis pulmonar. En: Aguado JM, Almirante B, Fortún J, editores. Protolos Clínicos de la Sociedad Española de Microbiología y Enfermedades Infecciosas (SEIMC). Sociedad Española de Microbiología y Enfermedades Infecciosas (SEIMC) 2006. p. 3-16.
3. Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis. 1994;13-908-14.
4. Sánchez-Albisua I, Baquero-Artigao F, del Castillo F, Borque C, García-Miguel MJ, Vidal ML. Twenty years of pulmonary tuberculosis in children: what has changed?. Pediatr Infect Dis J. 2002;21:49-53.
5. Al-Dossary FS, Ong LT, Correa AG, Starke JR. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy. Pediatr Infect Dis J. 2002;21:91-7.
6. Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis. 2003;3:624-32.
7. American Thoracic Society, CDC, and Infectious Disease Society of America. Treatment of tuberculosis. Recommendation and reports. MMWR. 2003;52:1-77.
8. Coll P. Fármacos con actividad frente a Mycobacterium tuberculosis. Enferm Infecc Microbiol Clin. 2003;21:299-308.
9. Sánchez-Albisua I, Vidal ML, Joya-Verde G, del Castillo F, de José MI, García-Hortelano J. Tolerance of pyrazinamide in short course chemotherapy for pulmonary tuberculosis in children. Pediatr Infect Dis J. 1997;16:760-3.
10. Graham SM, Daly HM, Banerjee A, Salaniponi FM, Harries AD. Ethambutol in tuberculosis: time to reconsider?. Arch Dis Chile. 1998;79:274-8.
11. Trebucq A. Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature. Int J Tuberc Lung Dis. 1997;1:1-5.
12. Donald PR Maher D, Maritz JS, Qazi S. Ethambutol dosage for the treatment of children: literature review and recommendations. Int J Tuberc Lung Dis. 2006;10:1328-30.
13. Mendez-Echevarria A, Baquero-Artigao F, García-Miguel MJ, Pascual SI, Velazquez R, del Castillo F. Visual evoked responses in children with tuberculosis treated with ethambutol. Pediatr Infect Dis J. 2007;26:92-3.
14. Sociedad Española de Neumología Pediátrica. Grupo de Trabajo "Tuberculosis Infantil". Protocolo del tratamiento de la tuberculosis infantil. An Esp Pediatr. 1998;48:89-97.
15. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax. 1998;53:536-48.
16. th ed. Elk Grove Village, IL: American Academy of Pediatrics 2006. p. 678-98.
17. Grupo de trabajo de tuberculosis de la Sociedad Española de Infectología Pediátrica (SEIP). Documento de consenso sobre el tratamiento de la tuberculosis pulmonar en niños. An Pediatr (Barc) 2007 (en prensa).
18. Frieden TR, Sterling T, Pablos-Méndez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York city. N Engl J Med. 1993;328:521-6.
19. nd ed. New York: Churchill Livingstone, Inc, 2003. p. 791-810.
20. th edition. Mosby, Inc. Philadelphia 2004. p. 731-67.
21. Baquero-Artigao F, García-Miguel MJ. Tuberculosis. Bol Pediatr. 2002;42:131-40.
22. Vidal ML, de la Vega F, Baquero-Artigao F, García-Miguel MJ, Borque C, del Castillo F. Tuberculosis cavitaria en la edad pediátrica. An Esp Ped. 1997;47:531-4.
23. Te Water Naude JM, Donald PR, Hussey GD, Kibel MA, Louw A, Perkins DR and Schaaf HS. Twice weekley vs. Daily chemotherapy for childhood tuberculosis. Pediatr Infect Dis J. 2000;19:405-10.
24. Aguado JM, Herrero JA, Gavalda J, Torre-Cisneros J, Blanes M, Rufí G, et al. Clinical presentation and outcome of tuberculosis in kidney, liver and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation. 1997;63:1278-86.
25. Verma A, Dhawan A, Wade JJ, Lim WH, Ruiz G, Price JF, et al. Mycobacterium tuberculosis infection in pediatric liver transplant recipients. Pediatr Infect Dis J. 2000;19:625-30.
26. Swaminathan S. Tuberculosis in HIV-infected children. Paediatr Respir Rev. 2004;5:225-30.
27. Stop TB Partnership Childhood TB Subgroup. Chapter 3: management of TB in the HIV-infected child. Int J Tuberc Lung Dis. 2006;10:1331-6.
28. LoBue PA, Moser KS. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego, California, United States, 1994-2003. Int J Tuberc Lung Dis. 2005;9:333-8.
29. Volmink, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2006;19:CD003343.
30. Loeffler AM. Pediatric tuberculosis. Semin Respir Infect. 2003;18:272-91.
31. Myers JP. New recommendations for the treatment of tuberculosis. Curr Opin Infect Dis. 2005;18:133-40.
32. Smith KC, Seaworth BJ. Drug-resistant tuberculosis: controversies and challenges in pediatrics. Expert Rev Anti Infect Ther. 2005;3:995-1010.
33. Grupo de trabajo de los talleres de 2001 y 2002 de la Unidad de Investigación en Tuberculosis de Barcelona. Prevención y control de las tuberculosis importadas. Med Clin (Barc). 2003;121:549-62.
34. Grupo de Estudio de Tuberculosis Resistente de Madrid. Estudio transversal multihospitalario de tuberculosis y resistencias en Madrid (octubre 1993-abril 1994). Med Clin (Barc). 1996;106:1-6.
35. Shaaf HS, Shean K, Donald PR. Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child. 2003;88:1106-11.
36. www.who.int/GlobalAtlas/predefinedReports/TB/PDF_Files/ES_2004_Brief.pdf
37. Gómez-Pastrana Durán, López Prieto MD, Ortiz Tardío J. Tuberculosis pulmonar multirresistente en un preescolar. Arch Bronconeumol. 1999;35:413-4.
38. Baquero-Artigao F. García-Miguel MJ, Merino R, García-Consuegra J, del Castillo F. Multidrug-resistant tuberculosis of the ankle: case report. Foot Ankle Int. 2006;27:642-4.
39. Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, Del Castillo, H et al. Community-Based Therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006;117:2022-9.
40. Chalumeau M, Tonnelier S, D'Athis P, Treluyer J.M, Gendrel D, Breart G, et al. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics. 2003;111:714-9.
41. De Arriba JJ, Solera J. Diagnóstico y tratamiento de la tuberculosis multirresistente. Rev Clin Esp. 2002;202:335-8.
42. Schaaf HS, Gie RP, Kennedy M, Beyers N, Hesseling PB, Donald PR. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics. 2002;109:765-71.